1-6 of 6
Nicholas Moore
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Characteristics of Rare Germline ATM Variants in Chronic Lymphocytic Leukemia (CLL)

Kiyomi Mashima, Benjamin L. Lampson, Aditi Gupta, Nicholas Moore, Anna Petrackova, Samantha J. Shupe, Stacey M. Fernandes, Amaro Taylor-Weiner, Riaz Gillani, Hoyin Chu, Seunghun Han, Sabrina Camp, Eric Kofman, Gad Getz, Catherine J. Wu, Eliezer Van Allen, Saud H AlDubayan, Jennifer R. Brown
Journal: Blood
Blood (2022) 140 (Supplement 1): 9853–9854.
https://doi.org/10.1182/blood-2022-167009
Published: 2022
Journal Articles

Effectiveness and Safety of the 15 Mg Dose of Rivaroxaban Compared with Vitamin k Antagonists in Patients with Atrial Fibrillation: Results from a Cohort Study in the Nationwide French Claims and Hospitalization Database (SNIIRAM)

Laurent Fauchier, MD PhD, Patrick Blin, MD PhD, Frédéric Sacher, MD PhD, Caroline Dureau-Pournin, MSc, Marie-Agnes Bernard, MSc, Regis Lassalle, Cécile Droz-Perroteau, PhD, Jean Dallongeville, MD PhD, Nicholas Moore, MD PhD FRCP
Journal: Blood
Blood (2017) 130 (Supplement 1): 2390.
https://doi.org/10.1182/blood.V130.Suppl_1.2390.2390
Published: 2017
Journal Articles

Imatinib and Nilotinib Intracytoplasmic Determination Levels.

Stephane Bouchet, Stephanie Dulucq, Karine Titier, Nicholas Moore, Mathieu Molimard, Francois-Xavier Mahon
Journal: Blood
Blood (2009) 114 (22): 2750.
https://doi.org/10.1182/blood.V114.22.2750.2750
Published: 2009
Journal Articles

Management of Chronic Myelogenous Leukemia Using Therapeutic Drug Monitoring of Imatinib: The French Experience of a Centralized Laboratory

Mathieu Molimard, Stephane Bouchet, Gabriel Etienne, Laurence Legros, Delphine Rea, Francoise Huguet, Karine Titier, Nicholas Moore, Josy Reiffers, Coralie Belanger, Francois-Xavier Mahon
Journal: Blood
Blood (2008) 112 (11): 3222.
https://doi.org/10.1182/blood.V112.11.3222.3222
Published: 2008
Journal Articles

Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia

Clinical Trials & Observations Brief Report
Stephane Picard, Karine Titier, Gabriel Etienne, Emmanuelle Teilhet, Dominique Ducint, Marie-Agnes Bernard, Regis Lassalle, Gerald Marit, Josy Reiffers, Bernard Begaud, Nicholas Moore, Mathieu Molimard, Francois-Xavier Mahon
Journal: Blood
Blood (2006) 109 (8): 3496–3499.
https://doi.org/10.1182/blood-2006-07-036012
Published: 2006
Journal Articles

Trough Plasma Imatinib Concentrations Are Associated with Both Cytogenetic and Molecular Responses to Standard-Dose Imatinib in Chronic Myeloid Leukemia.

Stephane Picard, MD, Karine Titier, Pharm D, Gabriel Etienne, MD, Regis Lassalle, MSc, Gerald Marit, MD, Josy Reiffers, MD, Bernard Begaud, MD, Nicholas Moore, MD,PhD, Mathieu Molimard, MD,PhD, Francois-Xavier Mahon, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2141.
https://doi.org/10.1182/blood.V108.11.2141.2141
Published: 2006